Announcements

OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, and OrbiMed Genesis GP LLC jointly filed a Form 4 with the SEC on September 23, 2026, disclosing beneficial ownership changes in Electra Therapeutics, Inc. (NASDAQ:ETRA) stemming from preferred stock conversions and common stock purchases made …

Director Anthony Mathew Eisen filed a Form 4 with the SEC on September 23, 2026, disclosing the sale of 18,000 shares of Block, Inc. Class A Common Stock across three consecutive trading days under a pre-established Rule 10b5-1 trading plan.

Carl L. Gordon, a director and 10% owner of Electra Therapeutics, Inc. (NASDAQ:ETRA), filed a Form 4 on September 23, 2026, reporting multiple transactions in common stock dated September 21, 2026, coinciding with the company's initial public offering.

A Statement of Changes in Beneficial Ownership for Asana, Inc. (NYSE:ASAN) was filed on September 23, 2026, disclosing two sales of Class A Common Stock by Chief Executive Officer and Director Daniel Mark Rogers on September 21 and September 22, 2026.

A Form 4 filed on September 23, 2026 with the U.S. Securities and Exchange Commission discloses that Katie Marie Colendich, General Counsel and Corporate Secretary of Asana, Inc. (NASDAQ:ASAN), sold a total of 15,910 shares of Class A Common Stock on September 21 and …

Asana, Inc. Chief Financial Officer Aziz Megji filed a Form 4 on September 23, 2026, disclosing two sales of Class A Common Stock totaling 38,668 shares on September 21 and September 23, 2026, both connected to RSU vesting tax obligations.

David R. Jolley, a director at Huckleberry.ai, Inc., filed a statement of changes in beneficial ownership on September 23, 2026, reporting a share withholding transaction in Class B Common Stock that occurred on September 21, 2026.